Piscataqua Savings Bank’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-50
Closed -$1.17K – 347
2024
Q2
$1.17K Hold
50
– – ﹤0.01% 337
2024
Q1
$1.65K Hold
50
– – ﹤0.01% 359
2023
Q4
$1.36K Hold
50
– – ﹤0.01% 337
2023
Q3
$1.2K Hold
50
– – ﹤0.01% 341
2023
Q2
$1.6K Hold
50
– – ﹤0.01% 329
2023
Q1
$1.53K Hold
50
– – ﹤0.01% 334
2022
Q4
$1.96K Hold
50
– – ﹤0.01% 316
2022
Q3
$2K Hold
50
– – ﹤0.01% 311
2022
Q2
$2K Hold
50
– – ﹤0.01% 308
2022
Q1
$3K Buy
+50
New +$3.28K ﹤0.01% 316

Other funds holding BEAM

Piscataqua Savings Bank's BEAM Position: Q3 2024 in Review

Piscataqua Savings Bank sold out of Beam Therapeutics (BEAM) in Q3 2024, closing a stake of 50 shares — an estimated $1.17K sold.

Piscataqua Savings Bank first reported a position in BEAM in Q1 2022 and held it in 10 quarters. The position peaked at $3K in Q1 2022. 221 funds tracked by Wall St. Rank hold BEAM as of Q3 2024.

  • Piscataqua Savings Bank reported no remaining Beam Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Piscataqua Savings Bank sold 50 Beam Therapeutics shares in Q3 2024, an estimated $1.17K.
  • Piscataqua Savings Bank first reported a position in Beam Therapeutics in Q1 2022 and held it in 10 quarters.
  • Piscataqua Savings Bank's Beam Therapeutics position peaked at $3K in Q1 2022.
  • 221 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2024.

Based on Piscataqua Savings Bank's 13F filing for Q3 2024, filed 15 Oct 2024.